Impact of preoperative percutaneous cardiopulmonary support on outcome following left ventricular assist device implantation

Circulation Journal

Volumn 76, Issue 1, 2012, Pages 88-95

  Toda, Koichi ^a   Fujita, Tomoyuki ^a   Kobayashi, Junjiro ^a   Shimahara, Yusuke ^a   Kitamura, Soichiro ^a   Seguchi, Osamu ^a   Murata, Yoshihiro ^a   Yanase, Masanobu ^a   Nakatani, Takeshi ^a  

^a Department of Cardiovascular Surgery ^*  (Japan)

Author keywords

Cardiomyopathy; Heart failure; Heart assist devices; Surgery; Transplantation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR;

ADULT; ARTICLE; ASSISTED CIRCULATION; BILIRUBIN BLOOD LEVEL; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; IMPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS CARDIOPULMONARY SUPPORT; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL TIME;

BILIRUBIN; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; FEMALE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; OXYGENATORS, MEMBRANE; PREOPERATIVE PERIOD; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84255168629     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0339     Document Type: Article

References (19)

1. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003; 125: 855-862.
2. Holman WL, Kormos RL, Naftel DC, Miller MA, Pagani FD, Blume E, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: A multi-institutional study. J Heart Lung Transplant 2009; 28: 44-50.
3. Shiga T, Kinugawa K, Hatano M, Yao A, Nishimura T, Endo M, et al. Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation. Circ J 2011; 75: 121-128.
4. Pagani FD, Aaronson KD, Dyke DB, Wright S, Swaniker F, Bartlett RH. Assessment of an extracorporeal life support to LVAD bridge to heart transplant. Ann Thorac Surg 2000; 70: 1977-1984.
5. Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T, et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. Circulation 1999; 100(19 Suppl): II206-II210.
6. Nakatani T. Heart transplantation. Circ J 2009; 73(Suppl A): A55-A60.
7. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: Implications for patient selection. Circulation 2007; 116: 497-505.
8. Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, et al. Risk factor analysis of long-term support with left ventricular assist system. Circ J 2010; 74: 715-722.
9. Masai T, Sawa Y, Ohtake S, Nishida T, Nishimura M, Fukushima N, et al. Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: Role of inflammatory response and hepatic microcirculation. Ann Thorac Surg 2002; 73: 549-555.
10. Johnson D, Mayers I. Multiple organ dysfunction syndrome: A narrative review. Can J Anaesth 2001; 48: 502-509.
11. Plötz FB, van Oeveren W, Bartlett RH, Wildevuur CR. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg 1993; 105: 823-832.
12. Magovern GJ Jr, Simpson KA. Extracorporeal membrane oxygenation for adult cardiac support: The Allegheny experience. Ann Thorac Surg 1999; 68: 655-661.
13. McCarthy PM, Smedira NO, Vargo RL, Goormastic M, Hobbs RE, Starling RC, et al. One hundred patients with the HeartMate left ventricular assist device: Evolving concepts and technology. J Thorac Cardiovasc Surg 1998; 115: 904-912.
14. Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: Analysis of 245 patients. Circulation 2002; 106(Suppl 1): I198-I202.
15. Kavarana MN, Pessin-Minsley MS, Urtecho J, Catanese KA, Flannery M, Oz MC, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: A continuing problem. Ann Thorac Surg 2002; 73: 745-750.
16. Kirsch M, Vermes E, Radu C, Streich B, Nakashima K, Mekontso- Dessap A, et al. Impact of preoperative hemodynamic support on early outcome in patients assisted with paracorporeal Thoratec ventricular assist device. Eur J Cardiothorac Surg 2008; 34: 262-267.
17. Fitzpatrick JR 3rd, Frederick JR, Hsu VM, Kozin ED, O'Hara ML, Howell E, et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 2008; 27: 1286-1292.
18. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357: 885-896.
19. George I, Colley P, Russo MJ, Martens TP, Burke E, Oz MC, et al. Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg 2008; 135: 1372-1379.